JHS Svendgaard Laboratories Limited Stock

Equities

JHS

INE544H01014

Personal Products

Market Closed - NSE India S.E. 07:43:52 2024-05-06 am EDT 5-day change 1st Jan Change
17.65 INR -1.94% Intraday chart for JHS Svendgaard Laboratories Limited -3.81% -30.65%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2022 863M 10.34M Sales 2023 1.03B 12.3M Capitalization 1.01B 12.06M
Net income 2022 -40M -479K Net income 2023 -155M -1.86M EV / Sales 2022 1.52 x
Net cash position 2022 18.37M 220K Net cash position 2023 235M 2.82M EV / Sales 2023 0.75 x
P/E ratio 2022
-32.6 x
P/E ratio 2023
-6.62 x
Employees 259
Yield 2022 *
-
Yield 2023
-
Free-Float 51.59%
More Fundamentals * Assessed data
Dynamic Chart
JHS Svendgaard Laboratories Limited cancelled the transaction of Vedic Cosmeceuticals Pvt. Ltd. CI
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
JHS Svendgaard's Joint CFO Resigns MT
JHS Svendgaard Laboratories Limited Announces the Resignation of Mr. Deepesh Sharma as Joint Chief Financial Officer CI
JHS Svendgaard Laboratories Limited Announces Cessation of Rohina Sanjay Sangtani as Independent Director CI
JHS Svendgaard Laboratories Limited completed the Spin-Off of JHS Svendgaard Retail Ventures Private Limited. CI
JHS Svendgaard Laboratories Limited agreed to acquire Vedic Cosmeceuticals Pvt. Ltd. CI
JHS Svendgaard Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
JHS Svendgaard Laboratories Limited Appoints Deepesh Sharma as Joint Chief Financial Officer CI
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
JHS Svendgaard Laboratories Limited Announces the Resignation of Neeraj Kumar as Joint Chief Financial Officer, Effective March 15, 2023 CI
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
JHS Svendgaard Laboratories Limited cancelled the transaction announced on September 2, 2022 CI
More news
1 day-1.94%
1 week-3.81%
Current month-5.61%
1 month-7.83%
3 months-45.78%
6 months-16.94%
Current year-30.65%
More quotes
1 week
17.65
Extreme 17.65
18.70
1 month
17.20
Extreme 17.2
19.30
Current year
15.55
Extreme 15.55
39.50
1 year
15.55
Extreme 15.55
39.50
3 years
13.60
Extreme 13.6
39.50
5 years
6.50
Extreme 6.5
39.50
10 years
6.50
Extreme 6.5
82.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 45 10-06-29
Director of Finance/CFO 38 09-04-05
Compliance Officer - 22-11-09
Members of the board TitleAgeSince
Director/Board Member 51 04-10-07
Director/Board Member 57 15-07-01
Chairman 64 20-06-22
More insiders
Date Price Change Volume
24-05-06 17.65 -1.94% 41,713
24-05-03 18 -1.91% 25,272
24-05-02 18.35 -1.87% 63,249
24-04-30 18.7 +1.91% 66,375

Delayed Quote NSE India S.E., May 06, 2024 at 07:43 am EDT

More quotes
JHS Svendgaard Laboratories Limited is an India-based private label manufacturer of oral care products. The Company is engaged in manufacturing a range of oral and dental products for national and international brands. The Company is involved in the manufacturing and exporting of oral care and hygiene products, including toothbrushes, toothpastes, mouthwash, sanitizers and job work of detergent powder. The Company also manufactures and sells oral care products under its brand, aquawhite and specializes in kids' oral care products. Its subsidiaries include JHS Svendgaard Brands Limited, JHS Svendgaard Mechanical and Warehouse Private Limited, and JHS Svendgaard Retail Ventures Private Limited.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW